Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

NCT03776500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

DRUG: PBTZ169
DRUG: Placebo

Sponsor

Innovative Medicines for Tuberculosis

Collaborators

[object Object]